News
Article
Author(s):
Researchers stated the integration of wearable sensors with AI could potentially revolutionize care for patients with atopic dermatitis.
Medical devices, particularly wearable biosensors, are increasingly being used for medical applications beyond traditional hospital settings. These devices, which can be embedded in clothing or adhere to the skin, monitor and record physical or biochemical parameters.1 Researchers behind a recent review wrote that dermatology stands to benefit from these advancements, particularly in managing atopic dermatitis (AD). Currently, assessing AD relies on subjective visual evaluations and patient reports, which can be inconsistent and impractical for tracking daily fluctuations in disease severity.2
The review stated wearable biosensors offer a promising solution by providing continuous, objective measurements of AD severity and treatment response. They could improve the accuracy of disease assessment and support the growing trend of virtual consultations in healthcare.With this in mind, the study aimed is to evaluate the existing evidence on the effectiveness of wearable biosensors for managing AD and determine their potential benefits in clinical practice.3
Results
Out of 57 abstracts reviewed, 39 papers were selected for detailed examination, focusing on advancements in wearable biosensor technology for monitoring AD such as:
Wearable Biosensor Modules
Integrated Fabrics and Textiles
Sensors Inserted into the Skin
Future Developments
Challenges and Barriers
Overall, the researchers determined that wearable biosensors have the potential to revolutionize AD management by providing continuous, objective data, though several technological and practical challenges must be addressed for widespread clinical adoption.
Conclusion
The review found that wearable sensors can be crucial for improving patient care, particularly for conditions like AD which requires accurate monitoring of disease flares and treatment responses. While current devices can track pruritus and correlate with disease severity, researchers stated they have limitations such as being usable only at night and not being suitable for all areas affected by AD. Advanced systems under development aim to measure skin barrier function, inflammation, and small molecules, potentially allowing for comprehensive home monitoring. The review found that integrating these systems with artificial intelligence could enable real-time treatment adjustments, significantly enhancing care for patients with skin conditions.
References